Literature DB >> 26261513

Knockdown of Nestin inhibits proliferation and migration of colorectal cancer cells.

Jing Li1, Rui Wang1, Lei Yang2, Qi Wu1, Qinwan Wang3, Zhengchao Nie1, Yongchun Yu4, Ji Ma3, Qiuhui Pan3.   

Abstract

Nestin, a member of type VI intermediate filament protein family, is widely expressed in mammalian nervous tissue and stem/precursor cells of non-neuronal normal tissues. Nestin has also been investigated to determine possible tumor-promoting functions. However, whether Nestin is involved in colorectal cancer (CRC) cells remains unclear. In this report, Nestin expression was upregulated in stromal cells of human CRC tissues. Endogenous Nestin expression in CRC cell lines SW480 and HCT116 was knocked down by a lentivirus. MTT and colony formation assays revealed that Nestin deletion significantly inhibits the proliferation of CRC cell lines; flow cytometer analysis showed that Nestin deletion causes cell cycle arrest at S phase. Transwell chamber and wound healing scratch assays also revealed that Nestin deletion suppresses cell migration. Our findings indicated that Nestin plays an essential role in CRC progression; thus, Nestin can be applied as a therapeutic target of CRC.

Entities:  

Keywords:  Nestin; colorectal cancer; metastasis

Mesh:

Substances:

Year:  2015        PMID: 26261513      PMCID: PMC4525847     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  32 in total

1.  Nestin-specific green fluorescent protein expression in embryonic stem cell-derived neural precursor cells used for transplantation.

Authors:  C Andressen; E Stöcker; F J Klinz; N Lenka; J Hescheler; B Fleischmann; S Arnhold; K Addicks
Journal:  Stem Cells       Date:  2001       Impact factor: 6.277

Review 2.  Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis.

Authors:  Toshiyuki Ishiwata; Yoko Matsuda; Zenya Naito
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

3.  Nestin-expressing cells in the pancreatic islets of Langerhans.

Authors:  E Hunziker; M Stein
Journal:  Biochem Biophys Res Commun       Date:  2000-04-29       Impact factor: 3.575

4.  Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis.

Authors:  Kazuya Yamahatsu; Yoko Matsuda; Toshiyuki Ishiwata; Eiji Uchida; Zenya Naito
Journal:  Int J Oncol       Date:  2012-01-13       Impact factor: 5.650

Review 5.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

6.  Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study.

Authors:  Hermann Brenner; Anne Marie Bouvier; Roberto Foschi; Monika Hackl; Inger Kristin Larsen; Valery Lemmens; Lucia Mangone; Silvia Francisci
Journal:  Int J Cancer       Date:  2011-08-03       Impact factor: 7.396

7.  Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.

Authors:  Te Liu; Fuhui Xu; Xiling Du; Dongmei Lai; Tianjin Liu; Yarui Zhao; Qin Huang; Lizhen Jiang; Wenbin Huang; Weiwei Cheng; Zhixue Liu
Journal:  Mol Cell Biochem       Date:  2010-03-12       Impact factor: 3.396

Review 8.  Colorectal cancer.

Authors:  David Cunningham; Wendy Atkin; Heinz-Josef Lenz; Henry T Lynch; Bruce Minsky; Bernard Nordlinger; Naureen Starling
Journal:  Lancet       Date:  2010-03-20       Impact factor: 79.321

9.  Cancer survival in Africa, Asia, and Central America: a population-based study.

Authors:  Rengaswamy Sankaranarayanan; Rajaraman Swaminathan; Hermann Brenner; Kexin Chen; Kee Seng Chia; Jian Guo Chen; Stephen C K Law; Yoon-Ok Ahn; Yong Bing Xiang; Balakrishna B Yeole; Hai Rim Shin; Viswanathan Shanta; Ze Hong Woo; Nimit Martin; Yupa Sumitsawan; Hutcha Sriplung; Adolfo Ortiz Barboza; Sultan Eser; Bhagwan M Nene; Krittika Suwanrungruang; Padmavathiamma Jayalekshmi; Rajesh Dikshit; Henry Wabinga; Divina B Esteban; Adriano Laudico; Yasmin Bhurgri; Ebrima Bah; Nasser Al-Hamdan
Journal:  Lancet Oncol       Date:  2009-12-10       Impact factor: 41.316

10.  Comparative evaluation of angiogenesis in gastric adenocarcinoma by nestin and CD34.

Authors:  Hyung-Seok Kim; Hun-Seok Kang; Conrad A Messam; Kyung-Whan Min; Chang-Soo Park
Journal:  Appl Immunohistochem Mol Morphol       Date:  2002-06
View more
  8 in total

1.  Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells.

Authors:  Wei-Qun Lu; Ying-Ying Hu; Xiao-Ping Lin; Wei Fan
Journal:  Oncotarget       Date:  2017-07-04

2.  Omental adipose tissue is a more suitable source of canine Mesenchymal stem cells.

Authors:  Francisca Bahamondes; Estefania Flores; Gino Cattaneo; Flavia Bruna; Paulette Conget
Journal:  BMC Vet Res       Date:  2017-06-08       Impact factor: 2.741

3.  Glycine Promotes the Survival of a Subpopulation of Neural Stem Cells.

Authors:  Abdelhamid Bekri; Pierre Drapeau
Journal:  Front Cell Dev Biol       Date:  2018-07-11

4.  The Structural Function of Nestin in Cell Body Softening is Correlated with Cancer Cell Metastasis.

Authors:  Ayana Yamagishi; Moe Susaki; Yuta Takano; Mei Mizusawa; Mari Mishima; Masumi Iijima; Shun'ichi Kuroda; Tomoko Okada; Chikashi Nakamura
Journal:  Int J Biol Sci       Date:  2019-06-02       Impact factor: 6.580

5.  Long noncoding RNA Ftx regulates the protein expression profile in HCT116 human colon cancer cells.

Authors:  Ruzhen Jia; Lulu Song; Zhiqiang Fei; Chengyong Qin; Qi Zhao
Journal:  Proteome Sci       Date:  2022-04-30       Impact factor: 2.882

6.  Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer.

Authors:  Kristi Krüger; Elisabeth Wik; Gøril Knutsvik; Hawa Nalwoga; Tor A Klingen; Jarle B Arnes; Ying Chen; Monica Mannelqvist; Konstantina Dimitrakopoulou; Ingunn M Stefansson; Even Birkeland; Turid Aas; Nicholas P Tobin; Inge Jonassen; Jonas Bergh; William D Foulkes; Lars A Akslen
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

7.  Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-β signaling pathway.

Authors:  Amber A Bokhari; Tabari M Baker; Batsukh Dorjbal; Sana Waheed; Christopher M Zahn; Chad A Hamilton; G Larry Maxwell; Viqar Syed
Journal:  Oncotarget       Date:  2016-10-25

8.  Nestin Expression Is Associated with Relapses in Head and Neck Lesions.

Authors:  Mario Pérez-Sayáns; Cintia M Chamorro-Petronacci; Fátima Baltazar; Fabio Ramoa Pires; Ángel Ínsua; Juan A Suárez-Quintanilla; José M Suárez-Peñaranda
Journal:  Diagnostics (Basel)       Date:  2021-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.